Submit your research today!
Expert Opinion on Investigational Drugs- Investigational drugs to impact metabolic dysfunctions that fuel the spectrum of chronic disease
About the special issue
In contrast to areas generally attacked in pharmaceutical development, a brief overview of health care expenditures shows that most of the health care costs come from inadequate treatment of common chronic diseases that cluster together and are significantly impacted by metabolic function. These conditions include type 2 diabetes, fatty liver disease, cardiovascular disease, and neurodegeneration including dementia.
There are currently no effective approaches to treat these overlapping disease states which until recently have seemed a natural consequence of aging. A new paradigm of drug discovery is suggested by molecular connections between common metabolic diseases.
Guest advisor and Key Opinion leader Dr Jerry Colca (Cirius Therapeutics, USA) has teamed up with Expert Opinion on Investigational Drugs in this special issue that brings together various approaches seeking to impact the metabolic dysfunctions that fuel the spectrum of chronic disease.
This collection will emphasize the discovery and evaluation of investigational drugs and drug combinations that might serve a broader purpose. This special interest volume will include agents that were initially targeted to treat specific inflammatory diseases, including type 2 diabetes, which might produce unexpected advantages for maintaining human health in response to environmental challenges.
There is no limitation on which disease states are targeted by investigational treatments. Topics may include:
• Reducing metabolic inflexibility
• Harnessing the power of immunomodulation
• Reducing neuroinflammation.
The issue welcomes authors to submit relevant editorials, reviews, interviews, and original research. If you are interested in contributing, or would like to learn more, then please reach out to the Commissioning Editor, Ryan Gilroy, who will be happy to assist.
Submission information
Submission Deadlines:
Standard track: 11th March 2024
Rapid track: 1st April 2024
Fast track: 29th May 2024
Accelerated Publication
Publish in 3 – 5 weeks from submission
Submission to acceptance: 2 – 3 weeks
1 – 2 weeks for peer review
1 week for author revision
Acceptance to online publication: 1 – 2 weeks, with proofs within 5 working days and 48 hours for author review
Cost per article: $7000 / €6200 / £5500
Publish in 7 – 9 weeks from submission
Submission to acceptance: 5 – 6 weeks
3 – 4 weeks for peer review
2 weeks for author revision
Acceptance to online publication: 2 – 3 weeks, with proofs within 10 working days
Cost per article: $3900 / €3400 / £3000
By publishing in Expert Opinion on Investigational Drugs you will:
Gain recognition from an international audience and increase your opportunities for future collaboration
Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
Increase the discoverability of your research with MEDLINE listings and more

When you are ready to submit your article, communicate the significance of your original research in a clear language to a broad audience using Plain Language Summary.

Open access makes published academic research freely and permanently available so anyone, anywhere can read and build upon this research. We champion researcher choice with a variety of open access publishing options to meet the unique needs of each author.

Considering publishing multimedia content? Research shows an increase in engagement and visibility when your research is accompanied by multimedia. Get in touch with Senior Editor Priti Nagda to discuss any specific requests.

Want to keep competitive advantage by getting your discoveries to market quickly? Or is time critical in your publishing strategy? Discover our Accelerated Publication options to help get your research into a high-quality, peer-reviewed journal, fast.

Explore the 2023 Expert Collection Calendar of special themed issues. Each special themed issue will be a one-stop resource for those interested in the field. By publishing your article, you can reap the benefits of the collection’s visibility and high impact.

Conference material supplements can include the following article types: Poster extracts, Conference abstracts, and Presentation extracts. Open access conference material supplements are peer-reviewed, permanent, and citable.

Pre-submission manuscript preparation can help you maximize the impact of your research and improve the quality of your manuscript. Services include English Language Editing, Scientific Editing, Manuscript formatting, and many more!